Gauge of Risk

One company says it will soon be offering a DNA-based suicide risk test, Technology Review reports.

Sundance Diagnostics plans to offer its saliva-based test, which is based on research out of the Max Planck Institute of Psychiatry, to doctors beginning next month for patients taking anti-depressants like Prozac or Zoloft. People just beginning anti-depressant treatment are sometimes at increased risk of suicide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Yoshiki Sasai Dies

High Hopes

All Along the Genome

In This Case…

California Testing

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.